<VariationArchive VariationID="2934424" VariationName="NM_015046.7(SETX):c.387_388+2del" VariationType="Deletion" Accession="VCV002934424" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-03-05" DateCreated="2024-02-29" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3094812" VariationID="2934424">
      <GeneList>
        <Gene Symbol="SETX" FullName="senataxin" GeneID="23064" HGNC_ID="HGNC:445" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>9q34.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="132261356" stop="132356744" display_start="132261356" display_stop="132356744" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="135136826" stop="135230371" display_start="135136826" display_stop="135230371" Strand="-" />
          </Location>
          <OMIM>608465</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_015046.7(SETX):c.387_388+2del</Name>
      <CanonicalSPDI>NC_000009.12:132346258:ACTAAC:AC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>9q34.13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="132346259" stop="132346262" display_start="132346259" display_stop="132346262" variantLength="4" positionVCF="132346258" referenceAlleleVCF="CACTA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="135221646" stop="135221649" display_start="135221646" display_stop="135221649" variantLength="4" positionVCF="135221645" referenceAlleleVCF="CACTA" alternateAlleleVCF="C" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.135221648_135221651del" Assembly="GRCh37">
            <Expression>NC_000009.11:g.135221648_135221651del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.12" sequenceAccession="NC_000009" sequenceVersion="12" change="g.132346261_132346264del" Assembly="GRCh38">
            <Expression>NC_000009.12:g.132346261_132346264del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007946.1" sequenceAccession="NG_007946" sequenceVersion="1" change="g.13724_13727del">
            <Expression>NG_007946.1:g.13724_13727del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015046.7" sequenceAccession="NM_015046" sequenceVersion="7" change="c.387_388+2del" MANESelect="true">
            <Expression>NM_015046.7:c.387_388+2del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001351528.2" sequenceAccession="NM_001351528" sequenceVersion="2" change="c.387_388+2del">
            <Expression>NM_001351528.2:c.387_388+2del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001351527.2" sequenceAccession="NM_001351527" sequenceVersion="2" change="c.387_388+2del">
            <Expression>NM_001351527.2:c.387_388+2del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_268" sequenceAccession="LRG_268">
            <Expression>LRG_268:g.13724_13727del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_015046.7(SETX):c.387_388+2del AND multiple conditions" Accession="RCV003796174" Version="1">
        <ClassifiedConditionList TraitSetID="11687">
          <ClassifiedCondition DB="MedGen" ID="C1865409">Amyotrophic lateral sclerosis type 4</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1853761">Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-05-10" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-05-10" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-02-29" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">14770181</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="11687" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4185" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Ataxia-oculomotor apraxia 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ataxia-ocular apraxia-2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2</ElementValue>
                <XRef ID="MONDO:0018996" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ataxia with Oculomotor Apraxia</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">AOA2</ElementValue>
                <XRef Type="MIM" ID="606002" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">SCAN2</ElementValue>
                <XRef Type="MIM" ID="606002" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12860" />
                <XRef ID="12860" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Ataxia with oculomotor apraxia type 2 (AOA2) is characterized by onset of ataxia between age three and 30 years after initial normal development, axonal sensorimotor neuropathy, oculomotor apraxia, cerebellar atrophy, and elevated serum concentration of alpha-fetoprotein (AFP).</Attribute>
                <XRef ID="NBK1154" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301333</ID>
                <ID Source="BookShelf">NBK1154</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301317</ID>
                <ID Source="BookShelf">NBK1138</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2010">
                <ID Source="PubMed">20050888</ID>
              </Citation>
              <XRef ID="64753" DB="Orphanet" />
              <XRef ID="C1853761" DB="MedGen" />
              <XRef ID="MONDO:0018996" DB="MONDO" />
              <XRef Type="MIM" ID="606002" DB="OMIM" />
            </Trait>
            <Trait ID="241" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">AMYOTROPHIC LATERAL SCLEROSIS 4, JUVENILE</ElementValue>
                <XRef Type="MIM" ID="602433" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608465.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608465.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608465.0008" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">NEURONOPATHY, DISTAL HEREDITARY MOTOR, WITH PYRAMIDAL FEATURES</ElementValue>
                <XRef Type="MIM" ID="602433" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Amyotrophic lateral sclerosis type 4</ElementValue>
                <XRef ID="MONDO:0011223" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ALS4</ElementValue>
                <XRef Type="MIM" ID="602433" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10502" />
                <XRef ID="10502" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301623</ID>
                <ID Source="BookShelf">NBK1450</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2007">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_AmyotrophicLateralSclerosis.pdf</URL>
                <CitationText>Orphanet, Amyotrophic lateral sclerosis, 2007</CitationText>
              </Citation>
              <XRef ID="357043" DB="Orphanet" />
              <XRef ID="C1865409" DB="MedGen" />
              <XRef ID="MONDO:0011223" DB="MONDO" />
              <XRef Type="MIM" ID="602433" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="8536561" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2024-02-28">
        <ClinVarSubmissionID localKey="13732639|MedGen:C1865409;C1853761" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004581029" DateUpdated="2024-02-28" DateCreated="2024-02-28" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">14770181</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. This variant is also known as c.387_388+2del. This variant has not been reported in the literature in individuals affected with SETX-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Val129Thrfs*31) in the SETX gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SETX are known to be pathogenic (PMID: 14770181).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SETX" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000009.11:g.135221646_135221649del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1865409" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1853761" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14224806</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8536561" TraitType="Disease" MappingType="XRef" MappingValue="C1865409" MappingRef="MedGen">
        <MedGen CUI="C1865409" Name="Amyotrophic lateral sclerosis type 4" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8536561" TraitType="Disease" MappingType="XRef" MappingValue="C1853761" MappingRef="MedGen">
        <MedGen CUI="C1853761" Name="Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

